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Fibroblast growth factor (FGF) signaling to the epithelium and mesenchyme mediated by FGF10 and
FGF9, respectively, controls cecal formation during embryonic development. In particular, mesenchy-
mal FGF10 signals to the epithelium via FGFR2b to induce epithelial cecal progenitor cell proliferation.
Yet the precise upstream mechanisms controlling mesenchymal FGF10 signaling are unknown.
Complete deletion of Fgf9 as well as of Pitx2, a gene encoding a homeobox transcription factor, both
lead to cecal agenesis. Herein, we used mouse genetic approaches to determine the precise contribution
of the epithelium and/or mesenchyme tissue compartments in this process. Using tissue compartment
speciﬁc Fgf9 versus Pitx2 loss of function approaches in the gut epithelium and/or mesenchyme, we
determined that FGF9 signals to the mesenchyme via Pitx2 to induce mesenchymal Fgf10 expression,
which in turn leads to epithelial cecal bud formation.
& 2012 Elsevier Inc. All rights reserved.Introduction
The cecum forms a pouch contiguous with the gastrointestinal
(GI) tract, lying between the ileum and the large intestine or
colon. Hosting a large reservoir of microbes, the cecum plays an
important role in the digestion of small food particles and
complex carbohydrates from plant matter. Thus, this part of the
gut tends to be more prominent in herbivores and omnivores than
obligate carnivores (Backhed et al., 2005; Eckburg et al., 2005).
In mouse embryogenesis, the cecum starts to form at E10.5 as a
mesenchymal expansion, followed by an epithelial evagination
(Burns et al., 2004). Epithelial evagination initiation is then
followed by elongation (growth), differentiation and arrest. To
date, however, the signals deﬁning cecal development remain
incompletely understood.
The cecum, like other parts of the intestine, is composed of two
layers: an endoderm-derived epithelium and the surrounding
mesoderm-derived mesenchyme. Epithelial–mesenchymal inter-
actions are required for proper budding morphogenesis and
differentiation in many organs including the gut (Cardoso, 2001;
Koike and Yasugi, 1999; Shannon and Hyatt, 2004). Fibroblastll rights reserved.
and Regenerative Medicine
spital Los Angeles, 4650 W
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i).growth factors, key elements of epithelial–mesenchymal interac-
tions in many tissues, have been described as major players in
controlling cecum formation. We have shown that loss of FGFR2b
signaling, in Fgf10 or Fgfr2IIIb knock-out (K.O.) embryos, results in
the formation of a mesenchymal expansion, but the epithelium
fails to proliferate and bud (Burns et al., 2004; Fairbanks et al.,
2004). Moreover, the guts of Fgf9 null embryos display complete
cecal agenesis, with the absence of both mesenchymal expansion
and epithelial budding. This is accompanied with decreased
mesenchymal proliferation as well as complete lack of Bmp4
and Fgf10 expression. In turn, absence of Fgf10 resulted in
decreased epithelial proliferation (Zhang et al., 2006). During
embryonic development, Fgf9 is mostly found in the epithelium
of the cecum but is also detected at lower levels in the mesench-
yme. However, compartment speciﬁc (epithelial vs. mesenchy-
mal) deletion of Fgf9 in the cecum has not yet been studied.
Pitx2 is a member of the homeobox gene family that encodes a
transcription factor initially identiﬁed as a gene mutated in
Axenfeld–Rieger Syndrome type I, a rare autosomal dominant
disorder that affects the development of the teeth, eyes and
umbilicus (Semina et al., 1996a). In the GI tract, Pitx2 is mainly
expressed in the mesenchyme of the developing cecum (Burns
et al., 2004) and it was recently reported that classical Pitx2
inactivation in mouse leads to cecal agenesis (Nichol and Saijoh,
2011). In addition, it has been shown that over-expression of
Hoxd12, another homeobox gene, phenocopies the loss of Fgf9 and
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(Zacchetti et al., 2007).
Developmental studies of branching processes in different
organs, e.g. cecum and lung, suggest that the mechanisms control-
ling branching are substantially conserved between organs. We have
reported previously that deletion of mesenchymal b-catenin in the
embryonic lung results in a loss of Pitx2 and Fgf10 expression. This
was associated with impaired epithelial and mesothelial FGF9
signaling to the mesenchyme due to decreased expression of
Fgfr2-IIIc (De Langhe et al., 2008). These results led us to propose
that an FGF9/Pitx2/FGF10 signaling pathway controls lung bud
formation. In the current study, we have used tissue speciﬁc Fgf9
and Pitx2 loss of function approaches in the gut epithelium and
mesenchyme to show that this signaling axis is active in the
developing gut, and demonstrate its importance for cecal formation.Materials and methods
Transgenic embryos
Dermo1-Cre (C57Bl/6 background), and Fgf9ﬂox/ﬂox mice were
obtained from Dr. David Ornitz (Washington University, Saint
Louis, MO (Yu et al., 2003)) and Dr. Fen Wang (Institute of
Biosciences and Technology, Houston, TX (Lin et al., 2006))
respectively. Pitx2ﬂox/ﬂox mice were previously described (Gage
et al., 1999). Dermo1-Cre mice were crossed with Pitx2ﬂox/ﬂox mice
to generate [Dermo1-Cre; Pitx2ﬂox/þ] that were then crossed with
Pitx2ﬂox/ﬂox mice to generate [Dermo1-Cre; Pitx2ﬂox/ﬂox] mutant
embryos (called hereafter Pitx2Dermo1-Cre). Shh-Cre mice were
purchased from The Jackson Laboratory and were used to inacti-
vate Pitx2 speciﬁcally in the epithelium. Shh-Cre mice were
crossed with Pitx2ﬂox/ﬂox mice to generate [Shh-Cre, Pitx2f/þ] that
were then crossed with Pitx2ﬂox/ﬂox mice to generate [Shh-Cre;
Pitx2ﬂox/ﬂox] mutant embryos (called hereafter Pitx2Shh-Cre). To
inactivate Fgf9 in the mesenchyme, we used Dermo1-Cre as
described above for Pitx2 inactivation. CMV-Cre mice were also
used to completely inactivate Fgf9 throughout the embryo includ-
ing both epithelium and mesenchyme of the gut. Animal experi-
ments were performed under the research protocol (31-08)
approved by the Animal Research Committee at Children’s Hos-
pital Los Angeles and in strict accordance with the recommenda-
tions in the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health. The approval identiﬁcation for
Children’s Hospital Los Angeles is AAALAC A3276-01.
Whole mount in situ hybridization (WISH)
Microdissected guts were ﬁxed in 4% paraformaldehyde (PFA)
for 20 min and dehydrated in ethanol. The samples were washed
twice in PBS for 10 min, transferred and stored in 70% ethanol
until use. Whole-mount in situ hybridization protocol was per-
formed as described (Winnier et al., 1995). The following mouse
cDNAs were used as templates for the synthesis of digoxigenin-
labeled riboprobes: a 528 bp fragment of Fgf9 (provided by Dr.
Ornitz), a 642 bp fragment of Shh (a kind gift from Dr Andrew
McMahon, Harvard University, Boston, MA), a 584 bp fragment of
Fgf10 (Bellusci et al., 1997), a 1.5 kb full-length mouse Bmp4
(Winnier et al., 1995), and a 559 bp fragment of Pitx2 present in
all 3 Pitx2 isoforms (De Langhe et al., 2008). Sense probes were
used for negative controls on E12.5 wild type ceca.
Proliferation analysis
Intraperitoneal injection of 0.2 mL bromodeoxyuridine (BrdU,
Amersham Biosciences UK) was given to pregnant females(4 pregnant females) carrying mutant and littermate control
embryos at E12.5. The females were sacriﬁced 15 min later and
the embryos were immediately placed in ice-cold Hank’s solution.
The ceca were dissected from the embryos, ﬁxed in 4% PFA,
gradually dehydrated in ethanol and processed for parafﬁn
sectioning. The ceca (n¼6) were uniformly dissected and oriented
away from the label of the embedding cassette or slide, with a
short segment of the Ileum and a segment of the colon towards
label. The embedded specimens were sectioned at 5 mm. The
sections were re-hydrated and the antigen was retrieved by
boiling the slides for 15 min in a microwave in 10 mM sodium
citrate (pH 6.0). The slides were incubated for 1 h with mono-
clonal anti-BrdU antibody (Clone BU-1) RPN 202 as recommended
by the manufacturer (Amersham Biosciences, UK). Cy3-labeled
anti-mouse secondary antibodies were used. The slides were then
mounted using Vectashield containing DAPI and photographed.
The epithelial and mesenchymal cells of the cecum were counted
separately for the number of total cells and BrdU-labeled cells.
The boundaries of the mutant ceca were deﬁned by the mesench-
ymal thickness and the curvature angles on each side, as illu-
strated in Fig. 4, panel K. The results are reported as the
percentage of BrdU-positive cells. Tissues from females not
injected with BrdU, and sections stained with secondary antibody
alone were used as negative controls. No staining was observed in
these specimens.
Quantitative PCR analyses
RNA was extracted from individually microdissected ceca from
Pitx2Dermo1-Cre mutant and littermate control embryos at E12.5 (n¼8).
One microgram of RNA was reverse-transcribed into cDNA using
Transcriptor High Fidelity cDNA Synthesis Kit (Roche Applied Science,
Indianapolis, USA) according to the manufacturer’s instructions. cDNA
(2 mL) was used for dual color Hydrolysis Probe—Universal probe
library based real time PCR, using the LightCycler 480 from Roche
Applied Science. Mouse GAPDH gene assay (Roche applied Science)
was used as the reference gene. The sets of primers and probe used
for each gene examined are Bmp4 (Forward: GAGGAGTTTCCATCAC-
GAAGA, Reverse: GCTCTGCCGAGGAGATCA, Probe 89), Fgf9 (Forward:
GGGGAGCTGTATGGATCAGA, Reverse: TCCCGTCCTTATTTAATGCAA,
Probe 12), Fgf10 (Forward: CGGGACCAAGAATGAAGACT, Reverse:
AACAACTCCAGATTTCCACTGA, Probe 80), Pitx2 (Forward: CCTTACG-
GAAGCCCGAGT, Reverse: CCAAGCCATTCTTGCACA, Probe 40), Fgfr2b
(Forward: CCCTACCTCAAGGTCCTGAA, Reverse: CATCCATCTCCGTCA-
CATTG, Probe 21), Fgfr2c (Forward: TGCATGGTTGACAGTTCTGC,
Reverse: TGCAGGCGATTAAGAAGACC, Probe 60). mRNA and water
were used as negative controls.
In vitro cecum culture
Ceca were microdissected from wild type C57Bl/6 mice at
E12.5, and placed atop polycarbonate ﬁlters (13 mm diameter,
8 mm pore size, Whatman) in 1 mL DMEM/F12 supplemented
with 5% Fetal Bovine Serum and 1% Penicillin/Streptomycin. Ceca
were then incubated with or without 250 ng/mL of human
recombinant FGF9 (n¼4 in duplicates) at 37 1C for 12 h in a
moist atmosphere (5% CO2).
Ectopic Pitx2 expression in cultured ﬁbroblasts
NIH 3T3 murine ﬁbroblasts (ATCC, #CRL-1658) were grown in
DMEM with 10% FBS to 80% conﬂuence. Cultures were transfected
with plasmid encoding human Pitx2 (pCI-HAPitx2a) (Kozlowski
and Walter, 2000) or empty vector (pCI) in Opti-MEM (Gibco Life
Technologies) using Lipofectamine 2000 (Invitrogen), following
the manufacturer’s recommended protocol. Forty-eight hours
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of Pitx2, Fgf9, and Fgf10 expression.
Statistical analyses
Statistical analyses were performed using Graphpad Prism
software. All data are expressed as mean7SEM. Comparisons of
the changes between controls and DTG were performed using
paired wilcoxon test. A pr0.05 was considered signiﬁcant. The
proliferation and quantitative PCR analyses were performed on
mutants and control littermates from at least 4 pregnant females.
Each litter carried 1–3 mutants and several controls. The statis-
tical analyses were performed on paired samples; in each experi-
ment, n designates the number of embryos.Results
Pitx2 expression in the developing mouse cecum
Previous studies have shown that Pitx2 is expressed in several
organs including the left lateral plate mesoderm, eye, brain,
pituitary glands, mandible, heart, lung, limbs and teeth (Arakawa
et al., 1998; De Langhe et al., 2008; Gage and Camper, 1997; Green
et al., 2001; Kitamura et al., 1997; Muccielli et al., 1996; Semina
et al., 1996b). It is also expressed in the developing mouse gut at
E12.5, the midgut at E16.5, and in the cecum at E10.5 and E11.5
(Burns et al., 2004; Campione et al., 1999; Hjalt et al., 2000).
However, the speciﬁc cellular compartments expressing Pitx2 haveFig. 1. Pitx2 expression in the embryonic cecum. (A)–(C) Whole mount in situ hybridiza
Pitx2 expression. Pitx2 was strongly expressed in both epithelium and mesenchyme o
intestine and absent in the colon. (D)–(F) Vibratome sections of the ceca were performed
sections showed expression of Pitx2 in both epithelium and mesenchyme of the cecum
Pitx2 at E12.5 (G) and E14.5 (H). The sections showed an epithelial expression of Pitx2 at
Col, colon; cec, cecum; epi, epithelium; and mes, mesenchyme. Scale bars in (A)–(C) anot been clearly deﬁned. To examine the spatial expression of Pitx2
in the developing GI tract, we carried out whole mount in situ
hybridization (WISH) for Pitx2 on whole isolated GI tracts between
E12.5 and E14.5. At these stages, Pitx2was strongly expressed in the
small intestine and in the cecum, but absent in the colon as shown
in Fig. 1A–C. Vibratome sections of the WISH samples showed that
Pitx2 is expressed in both epithelium and mesenchyme of the
cecum at all the developmental stages studied (Fig. 1D–F). Inter-
estingly, mesenchymal Pitx2 expression is stronger at the apex of
the bud compared to the stalk suggesting that it is directly involved
in the proximal–distal growth of the cecal tube. However, in the
small intestine Pitx2 expression is restricted to the epithelium early
on at E12.5 (Fig. 1G), while at E14.5, it is expressed in both
epithelium and mesenchyme (Fig. 1H).Speciﬁc deletion of Pitx2 in the mesenchyme results in cecal agenesis
It was recently reported that complete inactivation of Pitx2
results in cecal agenesis (Nichol and Saijoh, 2011). Since Pitx2 is
expressed in both epithelium and mesenchyme of the cecum as
shown in Fig. 1, it is unclear whether it is mesenchymal and/or
epithelial Pitx2 which is/are required for cecal budding and
elongation. We therefore examined the development of the
cecum in mice with Pitx2 speciﬁcally deleted from the mesench-
yme. Using the Dermo1-Cre driver line, Pitx2 deletion in the
mesenchyme resulted in embryonic lethality around E17.5 (data
not shown). Therefore control and Pitx2Dermo1-Cre embryos at
E11.5, E12.5, E14.5 and E16.5 were used for this study. We ﬁrsttion was performed on isolated E12.5 (A), E13.5 (B) and E14.5 (C) GI tracts to detect
f the cecum, while Pitx2 expression was restricted to the epithelium of the small
at 20 mm to show the localization of Pitx2 at E12.5 (D), E13.5 (E) and E14.5 (F). The
. (G) and (H) Vibratome sections of the small intestine to show the localization of
E12.5 (G) and both mesenchymal and epithelial expression at E14.5 (H). Ile, ileum;
re 500 mm, scale bars in (D)–(I) are 100 mm.
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Pitx2Dermo1-Cre but not control (littermate Dermo1-Cre; Pitx2f/þ)
ceca at E11.5 (Fig. 2A and B). Note that Pitx2 expression in the
epithelium of the mutant gut was still maintained. Dermo1-Cre;
Pitx2f/þ animals were morphologically similar to their control
littermates at all stages (470 embryos were analyzed for each
genotype at each time point). At E12.5, the control cecum
normally developed into a mesenchymal protrusion surrounding
a layer of epithelial bud (Fig. 2C). In E12.5 Pitx2Dermo1-Cre mutants,
both the mesenchymal protrusion and epithelial buds were
absent (n¼70/70 embryos examined) even though the character-
istic bending of the gut at that location was still visible (Fig. 2D).
At E14.5 the wild type cecum continued to develop (Fig. 2E)
while the mutant cecum did not show any evidence of budding or
elongation (Fig. 2F). A similar observation was made at E16.5
(Fig. 2G and H). In contrast to mesenchymal deletion, removing
Pitx2 from the epithelium using the Shh-Cre driver line did not
affect cecal formation (Fig. 2I and J). Thus, we conclude that
mesenchymal Pitx2 but not epithelial Pitx2 is required for cecal
bud formation. Interestingly, we also observed that the small
intestines of Pitx2Dermo1-Cre embryos are shorter than those of
control littermates (Fig. 2L; 78.6% of the length of the controls at
E14.5, p¼0.0125, n¼7, white arrows indicate the location of the
cecum), whereas the colon lengths were similar (Fig. 2M).
Additionally, around 65% of the mutants developed Meckel’s
diverticulum (black arrow, Fig. 2L) on the small intestine.
Decreased epithelial and mesenchymal cell proliferation after
mesenchymal deletion of Pitx2
At E12.5, the epithelial and mesenchymal buds were normal in
control embryos (Fig. 3A), whereas no epithelial or mesenchymal
buds were observed in the mutant as shown by H&E staining
(Fig. 3B). Since both mesenchymal and epithelial budding wasFig. 2. Deletion of mesenchymal Pitx2 leads to cecal agenesis. (A) Pitx2 whole mount
mutants (B) as compared to the controls at E11.5 (A). Comparison of the cecum develop
and (G) and Pitx2Dermo1-Cre gut (D), (F), and (H). Pitx2Dermo1-Cre mutants did not show any
developing cecum (C), (E), and (G). (I) and (J) Comparison of control (I) versus Pitx2Shh-
cecum compared to the control. (K) WISH using sense probe for Pitx2 did not show any s
tracts of Pitx2Dermo1-Cre and littermate controls. White arrows show the location of the ce
the small intestine (SI) and colon lengths of Pitx2Dermo1-Cre mutants normalized to contro
while no difference is observed for the colons. The bars represent means7s.e.m. Asteraffected in the mutant cecum, we assessed cell proliferation in
these compartments using BrdU incorporation. Both epithelial and
mesenchymal proliferations were reduced in the Pitx2Dermo1-Cre
cecum (Fig. 3D and F) as compared to controls (Fig. 3C and E).
Proliferation was reduced from 36.9% to 23.1% in the mesenchyme
(Fig. 3G) (p¼0.05, n¼6) and from 45.2% to 27.4% in the epithelial
cells (p¼0.05, n¼6) (Fig. 3G).
Fgf10 and Fgfr2b are down-regulated in the Pitx2Dermo1-Cre cecum
Loss of either Fgf9 or Fgf10 reduces proliferation in the
epithelium and mesenchyme of the cecum (Burns et al., 2004;
Zhang et al., 2006). Furthermore, the abnormalities we observed
in the Pitx2Dermo1-Cre mutant cecum phenocopy those reported in
Fgf9 mutants. Therefore, we examined the expression of Fgf9,
Fgf10 and Bmp4 in Pitx2Dermo1-Cre and control littermates using
WISH and RT-qPCR. Fgf10 was expressed in the mesenchyme of
the cecum at E12.5 (Fig. 4A). However, in Pitx2Dermo1-Cre embryos,
it was absent from the cecal mesenchyme as shown by WISH
(Fig. 4B). Bmp4 was expressed exclusively in the mesenchyme of
the wild type cecum at E12.5 (Fig. 4C) and this expression was
maintained in the Pitx2Dermo1-Cre mutant embryos (Fig. 4D). In
contrast to Bmp4, Fgf9 was expressed in both epithelium and
mesenchyme of control cecum at E12.5 (Fig. 4E), whereas in
Pitx2Dermo1-Cre animals it was only expressed in the epithelium
(Fig. 4F, compare insets in E and F). WISH using sense probes for
Fgf10, Bmp4 and Fgf9 on E12.5 wild-type ceca did not show any
staining (Fig. 4G–I respectively).
The WISH data results were conﬁrmed by qRT-PCR. The results
showed a signiﬁcant decrease in Pitx2, Fgf10 and Fgf9 levels in
the mutant ceca as compared to controls (p¼0.024, p¼0.025
and p¼0.05 respectively; Fig. 4J). No signiﬁcant changes were
detected in expression of Bmp4 or Fgfr2c. Moreover, we found a
statistically signiﬁcant reduction in Fgfr2b (p¼0.023) in the Pitx2in situ hybridization (WMISH) conﬁrms the deletion of mesenchymal Pitx2 in the
ment in E12.5 (C) and (D), E14.5 (E) and (F), and E16.5 (G) and (H) WT gut (C), (E),
cecum formation (D), (F), and (H) whereas wild type littermates showed a normal
Cre (J) ceca at E14.5. No difference is noticeable in the development of the mutant
taining in E12.5 wild type cecum. (L) Whole mount view of representative E14.5 GI
cum on each GI tract. The black arrow shows the diverticulum (M) quantiﬁcation of
l littermates (100%) indicate that mutant SI are shorter when compared to controls
isk indicates a statistical difference (p¼0.0214; n¼7). Scale bars are 500 mm.
Fig. 3. Decrease in cell proliferation in Pitx2Dermo1-Cre mutants. (A) and (B) Parafﬁn
sections from E12.5 control (A) and Pitx2Dermo1-Cre (B) stained with H&E. Note the
absence of cecal bud in the mutant along with a decreased mesenchyme when
compared to the control. (C)–(F) BrdU labeling of control (C) and (E) and mutant
(D) and (F) cecal sections showed a decreased proliferation in both epithelium and
mesenchyme of the mutants. (G) Quantiﬁcation of the number of BrdU positive
cells in the epithelium and the mesenchyme (n¼6). Scale bars are 50 mm.
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Fgf10 expression requires mesenchymal Pitx2. Conversely, we
previously reported that deletion of Fgf10 in the cecum does not
affect the expression of mesenchymal Pitx2 (Burns et al., 2004).
Taken together, these observations indicate that Fgf10 is down-
stream of mesenchymal Pitx2. In addition, unlike what was
observed in the lung (De Langhe et al., 2008), it does not appear
that mesenchymal Pitx2 regulates Fgfr2c expression.
Fgf9 regulates Pitx2 expression in the cecum
Speciﬁc mesenchymal Pitx2 inactivation mice show a cecum
phenotype similar to the Fgf9 knockout. However, Fig. 4 shows
that epithelial Fgf9 expression does not depend on mesenchymal
Pitx2 expression. To test whether FGF9 can control Pitx2 expres-
sion, we exposed in vitro cultures of E12.5 cecum for 12 h to
250 ng/mL of recombinant FGF9 in vitro. FGF9-treated ceca
showed signiﬁcant increase in Pitx2 and Fgf10 expression,
assessed by qRT-PCR, as compared to controls (Fig. 5A), while
no changes were observed in the expression of Fgfr2b or Fgfr2c.
To investigate whether mesenchymal Fgf9 controls the expressionof Pitx2 in the mesenchyme, we generated mutant embryos with
mesenchymal (Fgf9Dermo1-Cre) or global (Fgf9CMV-Cre) deletion of
Fgf9, using Fgf9f/f mice crossed with Dermo1-Cre and CMV-Cre
respectively. At E14.5, the wild type embryo has a well-developed
epithelial cecal bud surrounded by a thick layer of mesenchyme
(Fig. 5B). Fgf9Dermo1-Cre embryos with speciﬁc inactivation in the
mesenchyme displayed a hypoplastic cecum with a narrowed
epithelial lumen surrounded by a thinner mesenchyme (Fig. 5C)
as compared to the control. By comparison, Fgf9CMV-Cre embryos
showed a more severe phenotype with a substantially attenuated
epithelial and mesenchymal cecal bud (Fig. 5D). After deletion of
mesenchymal Fgf9, Pitx2 was still strongly expressed albeit at a
lower level in the Fgf9Dermo1-Cre cecum as compared to control
(Fig. 5E and F). Global deletion of Fgf9 completely abolished the
expression of Pitx2 in the mesenchyme of the Fgf9CMV-Cre gut
(Fig. 5G). However, Pitx2 expression is still detectable in the
epithelium at a signiﬁcant level. In contrast, Shh expression was
not affected by either mesenchymal or global Fgf9 deletion
(Fig. 5H–J). We conclude that both mesenchymal and epithelial
Fgf9 are important for the formation of the cecum.
Pitx2 induces Fgf10 expression in the absence of Fgf9
To test whether Pitx2 can directly induce the expression of
Fgf10 in the absence of Fgf9, we used an in vitro model of 3T3 cells
to overexpress Pitx2. We ﬁrst conﬁrmed the absence of Fgf9 in
these cells by PCR. The transfection of these cells with Pitx2a
vector resulted in a 7-fold increase of Pitx2 as assessed by qRT-
PCR (data not shown). Moreover, the overexpression of Pitx2
resulted in a signiﬁcant increase (40%) in the expression of Fgf10
as compared to the control or the empty vector (Fig. 6). In
contrast, no change in Fgf10 was induced by the empty vector.Discussion
In humans, the cecum is an important functional part of the GI
tract. It is populated by a biodiverse microbiota that play an
important role in the digestion of complex carbohydrates deliv-
ered from the small intestine (Backhed et al., 2005; Eckburg et al.,
2005), and is also a signiﬁcant site of intestinal immune activity.
In the mouse, the cecum develops in 3 phases: bud initiation, bud
elongation and bud arrest. To date, the molecular mechanisms
regulating these phases are poorly understood. It was recently
demonstrated that Pitx2 null embryos display cecal agenesis
(Nichol and Saijoh, 2011). In this report, we show that mesench-
ymal Pitx2 regulates both the formation of the cecal mesenchymal
bud and the subsequent epithelial bud induction. Absence of
mesenchymal Pitx2 translates into cecal agenesis. However,
Pitx2Dermo1-Cre mutants display a less severe phenotype than the
Pitx2 null, which was expected. This is due in part to the fact that
Pitx2 expression in the epithelium is still maintained. Pitx2 is
mainly implicated in controlling left–right asymmetry during
embryonic development (Liu et al., 2001) and is also known to
regulate cell proliferation through cyclinD1 expression in several
organs such as the gonads (Rodriguez-Leon et al., 2008). Consis-
tent with previous reports, our data show that cecal agenesis is
associated with decreased proliferation in both the epithelium
and mesenchyme of the cecum (Burns et al., 2004; Zhang et al.,
2006). However, deletion of epithelial Pitx2 did not adversely
affect cecal formation.
Pitx2 has two homologs, Pitx1 and Pitx3. Pitx1 is expressed in
the epithelium and mesenchyme of the developing gut and the
cecum (Lanctot et al., 1997; Zacchetti et al., 2007). It is absent in
the cecum of mice lacking HoxD cluster genes (homeobox
domain) that also present with cecal agenesis. Fgf10 expression
Fig. 4. Gene expression in E12.5 Pitx2Dermo1-Cre cecum. Comparison of Fgf10, Bmp4 (C) and (D) and Fgf9 (E) and (F) expression by WMISH in ceca isolated at E12.5. Fgf10 and
Bmp4 are expressed in the mesenchyme of wild type E12.5 cecum ((A) and (C) respectively). Fgf10 expression is absent from the cecum of the mutants (B) while Bmp4
expression is maintained in the mutant ceca (D). Fgf9 is expressed in both epithelium and mesenchyme of E12.5 WT cecum (E) and its expression is restricted to the
epithelium of the mutant ceca (F). Insets in (E) and (F) show a high magniﬁcation of the cecal bud. (G)–(I) Negative controls using the sense probes for Fgf10 (G), Bmp4
(H) and Fgf9 (I) did not show any staining. (J) Quantiﬁcation of gene expression by RT-qPCR (n¼12). (K) Schematic illustration of the parts of the ceca from controls and
mutants that were used for the analyses. Scale bars are 500 mm.
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suggesting a role for Pitx1 in cecal formation as well as Fgf10
expression. However, Pitx1 null embryos display normal cecum
formation (Supplementary Fig. S1). Pitx3 is mainly expressed in
skeletal muscle, eye, midbrain and forebrain as demonstrated by
WISH and Pitx3–GFP or Pitx3–LacZ reporter mice (Coulon et al.,
2007; Grealish et al., 2010; L’Honore et al., 2007; Zhao et al.,
2004). Pitx3 expression in developing gut or cecum has not been
reported. This indicates a unique role for mesenchymal Pitx2 in
coordinating cecal formation. However, we cannot exclude a
possible functional redundancy between Pitx1 and Pitx2 in the
epithelium.An FGF9–Pitx2–FGF10 signaling pathway controls cecal formation
We have previously shown that, in lung development, Pitx2
positively regulates Fgfr2c transcription. Through this mechanism,
Pitx2 directly impacts the ability of the mesenchyme to respond
to FGF9 and thus to maintain Fgf10 expression (De Langhe et al.,
2008). Moreover, Fgf10 is strongly expressed in the mesenchyme
of the cecum (El Agha et al., 2012). These results led us to propose
that an FGF9/Pitx2/FGF10 signaling pathway could control bud
formation. Our current results demonstrate that this model
applies, at least partially, to the cecum as we found that epithelial
FGF9 controls mesenchymal Pitx2 expression, which in turn
Fig. 5. FGF9 controls the expression of Pitx2 and Fgf10. (A) qPCR for Pitx2, Fgf10, Fgfr2b and Fgfr2c after in vitro culture of ceca in the absence or presence of 250 ng/mL rh
FGF9 for 12 h (n¼4 in duplicates). (B)–(D) Comparison of the cecum development at E14.5 in wild type (B), Fgf9Dermo1-Cre (C) and Fgf9CMV-Cre (D) mutants. The wild type
cecum has a well developed cecal bud surrounded by a thick layer of mesenchyme (B); deletion of Fgf9 in the mesenchyme resulted in a thinning of the mesenchymal layer
surrounding the epithelial bud that forms properly (C), whereas the complete deletion of Fgf9 resulted in impaired cecal bud formation (D). Pitx2 (E)–(G) and Shh (H)–(J)
expression in mutants compared to the control. Note the complete lack of Pitx2 expression in the mesenchyme of Fgf9CMV-Cre gut ((G) inset shows a high magniﬁcation of
the cecal bud). No detectable change in Shh expression was detected in either mutants (I) and (J) compared to control (H). Scale bars are 250 mm.
Fig. 6. Pitx2 overexpression induced the expression of Fgf10 in the absence of Fgf9.
Relative Fgf10 mRNA expression showed signiﬁcant increase of Fgf10 expression
after transfection of NIH 3T3 cells (negative for Fgf9) with Pitx2a vector (n¼4,
p¼0.03).
D. Al Alam et al. / Developmental Biology 369 (2012) 340–348346controls mesenchymal Fgf10 expression. However, Fgfr2c expres-
sion was not changed upon mesenchymal Pitx2 inactivation,
suggesting that Pitx2 does not control Fgfr2c or that other
compensatory pathways could be involved. Further studies willbe needed to characterize the regulators of Fgfr2c expression in
the cecal mesenchyme.
Fibroblast Growth factors 9 and 10 along with their cognate
receptors FGFR2c and FGFR2b, respectively, are known regulators
of cecal development. Fgf9 is essential for mesenchymal cecal bud
induction and controls Fgf10 expression. In turn, the FGF10/
FGFR2b pathway is critical for the subsequent elongation phase
of the epithelial cecal bud into the newly formed cecal mesench-
yme (Burns et al., 2004; Fairbanks et al., 2004; Zhang et al., 2006).
FGF10, from the mesenchyme, signals to the epithelium via its
receptor FGFR2b. The FGF10/FGFR2b pathway is known to induce
epithelial branching in several organ systems including lung,
salivary glands and mammary glands (Min et al., 1998; Parsa
et al., 2008; Sekine et al., 1999; Steinberg et al., 2005). Both Fgf10
and Fgfr2b null mice fail to develop a cecal epithelial bud (Burns
et al., 2004) but still exhibit a signiﬁcant mesenchymal bud while
Fgf9 null embryos exhibited a complete absence of the epithelial
and mesenchymal cecal bud. In this report we show that, similar
to total Fgf9 knockout, deletion of Pitx2 in the mesenchyme
results in the complete absence of mesenchymal cecal bud
formation. Moreover, we showed that Pitx2 induces the expres-
sion of Fgf10 in the absence of Fgf9, therefore positioning Pitx2
downstream of Fgf9. These observations, along with the in vitro
cecal cultures in the presence of recombinant FGF9, conﬁrm our
D. Al Alam et al. / Developmental Biology 369 (2012) 340–348 347hypothesis that FGF9 acts upstream of Pitx2 during cecal devel-
opment. In addition, the decrease of Fgf10 and Fgfr2b expression
in Pitx2Dermo1-Cre mutants is consistent with what was observed in
the Fgf9 null mutants.Epithelial but not mesenchymal Fgf9 is required for cecal budding
It has been proposed that epithelial but not mesenchymal Fgf9
is required for cecal budding and elongation (Zhang et al., 2006).
Our results demonstrate that mesenchymal Fgf9 is also an
important player in the elongation of the cecal bud as mesench-
ymal Fgf9 deletion resulted in the formation of a shorter cecum
and a thinner mesenchyme, accompanied with a decrease in Pitx2
expression. However, global Fgf9 deletion resulted in a much
more severe phenotype, displaying only an attempt to form a
rudimentary epithelial bud and a complete absence of mesench-
ymal Pitx2 expression. This rudimentary bud formation upon
complete Fgf9 deletion could be due to variable or partial
penetrance of the previously described Fgf9 null phenotype.
However, as implied by global Fgf9 inactivation, epithelial Fgf9
is likely the key player in the initial steps of cecal formation.An FGF9–Pitx2 axis controls the elongation of the small intestine
Fgf10 expression is restricted to the caudal cecal mesenchyme
while Fgf9 is expressed in both the epithelium and the mesench-
yme of the developing small intestine, cecum and colon (Zhang
et al., 2006). Interestingly, in the small intestine Pitx2 expression is
restricted to the epithelium during early stages of development
(E11.5–E12.5) and then starts to be expressed in the mesenchyme
around E13.5. Our data indicate that mesenchymal Pitx2 expres-
sion is critical for the proper extension of the small intestine during
development. Fgf9 null mutants showed a decrease in the length of
the small intestine (about 80% of the control length at E14.5)
(Zhang et al., 2006) similar to that observed for Pitx2Dermo1-Cre
mutants. In both mutants (Fgf9 and Pitx2), this difference is
noticeable mostly from E14.5 onwards, a time-point when Pitx2
is expressed in the mesenchyme. Taken together, these ﬁndings
suggest that Pitx2 function downstream of Fgf9 is important for the
elongation of the small intestine. This possibility is supported by
the fact that the development of the colon, where Fgf9 is expressed
but not Pitx2, is not affected by the deletion of Fgf9 (Geske et al.,
2008). We therefore speculate an important role for Pitx2 in
controlling the elongation of the small intestine. Further analyses
to test that hypothesis could be carried out. For example, expres-
sing Pitx2 in the colon mesenchyme (where it is normally absent)Fig. 7. Model of FGF/Pitx2/FGF10 signaling in the developing cecum. We propose
that epithelial FGF9 acts via FGFRc receptor isoforms in the mesenchyme to
control cecal mesenchyme expansion and Fgf10 expression. Both activities are
mediated by Pitx2. In turn FGF10 acts on the epithelium to trigger the invasion of
the epithelial bud into the cecal mesenchyme.could help determine whether or not this is sufﬁcient to trigger
excessive elongation.
In conclusion, Fgf9 compartment-speciﬁc deletions suggest
that both epithelial and mesenchymal FGF9 are important for
the proper formation of the cecum and that both sources control
mesenchymal Pitx2 expression. In addition, the phenotype of
Pitx2Dermo1-Cre mice suggests that FGF9 controls mesenchymal
proliferation and acts mainly through mesenchymal Pitx2 to
induce Fgf10 expression. In turn, FGF10 controls cecal epithelial
budding and elongation (Fig. 7).Acknowledgments
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